Efficacy and safety of alemtuzumab in 104 patients with active relapsing- remitting MS: one-year follow-up in France

Affiliation auteurs!!!! Error affiliation !!!!
TitreEfficacy and safety of alemtuzumab in 104 patients with active relapsing- remitting MS: one-year follow-up in France
Type de publicationJournal Article
Year of Publication2016
AuteursAyrignac X., Collongues N., De Seze J., Vermersch P., Biotti D., Brassat D., Carra-Dalliere C., Vukusic S., Durand-Dubief F., Edan G., Lepage E., Deburghgraeve V., Maillart E., Papeix C., Alla P., Berger E., Bourre B., Casez O., Pittion S., Debouverie M., Theaudin M., Derache N., Defer G., Gout O., Deschamps R., Tourbah A., Zagnoli F., Ruet A., Ouallet J.C, Brochet B., Manchon E., Moreau T., Fromont A., Clavelou P., Taithe F., Guennoc A.M, Camdessanche J.P, Carpentier A., Coman I., Audoin B., Pelletier J., Rico A., Magy L., Ciron J., Wiertlewski S., Laplaud D., de Broucker T., Lebrun C., Cohen M., Labauge P., Plaques CFrancophon, Plaques SFrancophon
JournalMULTIPLE SCLEROSIS JOURNAL
Volume22
Pagination622-624
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN1352-4585